Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Met-His-Lys)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000666 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000670 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000045 AN000075 Plasma metabolomics: Comparison of non-diabetic controls with T1D patients Blood Human Mayo Clinic Raw MS Intensities
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
  logo